Table 2.
EC‐MR+/+ TAC | EC‐MR−/− TAC | |||
---|---|---|---|---|
Lung weight |
Sham 8.59 ± 0.19 |
TAC 8.65 ± 0.2 |
Sham 8.58 ± 0.06 |
TAC 8.92 ± 0.19 |
Hemodynamics | ||||
Systolic pressure (mmHg) | 106.2 ± 2.676 | 164.5 ± 4.435*** | 105.4 ± 3.925 | 163 ± 8.4** |
End diastolic pressure (mmHg) | 4.44 ± 0.74 | 14.86 ± 2.834a | 5.267 ± 1.317 | 13.13 ± 3.506 |
Effective arterial elastance (mmHg/μL) | 8.776 ± 2.03 | 11.27 ± 1.041 | 8.22 ± 2.934 | 11.98 ± 1.482 |
dP/dtmax | 9119 ± 468.3 | 8235 ± 653.1 | 8861 ± 728.2 | 7818 ± 761.7 |
dP/dtmin | −9715 ± 793.2 | −8985 ± 1043 | −8940 ± 670.7 | −8863 ± 655 |
Tau " (msec) | 4.54 ± 0.21 | 4.625 ± 0.30 | 4.367 ± 0.37 | 4.65 ± 0.237 |
End diastolic volume (μL) | 35.78 ± 9.259 | 42.13 ± 5.101 | 35.8 ± 11.1 | 36.79 ± 4.56 |
End systolic volume (μL) | 25.11 ± 5.786 | 31.91 ± 3.811 | 23.99 ± 5.615 | 30.1 ± 3.881 |
Cardiac output (μL/min) | 7544 ± 1890 | 7136 ± 558.5 | 7475 ± 2085 | 5810 ± 815.7 |
ESPVR (mmHg/μL) | 4.078 ± 0.892 | 4.888 ± 0.763 | 3.65 ± 0.496 | 6.135 ± 1.355 |
PRSW (mmHg/μL) | 44.9 ± 11.73 | 70.02 ± 10.17 | 65.14 ± 9.932 | 81.09 ± 16.05 |
Heart rate (bpm) | 490.4 ± 17.57 | 493.9 ± 10.34 | 481.7 ± 45.08 | 449.3 ± 21.27 |
Echocardiography | ||||
End diastolic diameter (mm) | 3.88 ± 0.14 | 3.92 ± 0.12 | 3.946 ± 0.10 | 4.05 ± 0.14 |
End systolic diameter (mm) | 2.61 ± 0.19 | 3.21 ± 0.12 | 2.99 ± 0.01 | 3.03 ± 0.21 |
n = 5 EC‐MR+/+ Sham, 8 EC‐MR+/+ TAC, 3 EC‐MR−/− Sham, 8 EC‐MR−/− TAC. Mean ± SEM is indicated for each parameter. Statistics D'Agostino & Pearson normality test, followed by unpaired Student's t‐test. **P < 0.01; ***P < 0.005.
ESPVR, end systolic pressure–volume relationship; PRSW, preload recruitable stroke work.
Versus Sham per genotype.